Expected Rebound in Elective and Medically Necessary Procedures

Expected Rebound in Elective and Medically Necessary Procedures

Rafi Musher • May 26, 2020
Rafi Musher • May 26, 2020

Share

Stax's short term outlook (1-6 month) across the healthcare sector.

Many healthcare companies have similar questions about return to patient volumes, which locations will see a return to procedures, and the long-term prognosis for healthcare. To facilitate the process and speed up the effort, Stax has initiated new field research on expectations for return to procedures and developed a fast framework to help management teams, boards of directors, and investors determine the short, medium, and long- term implications for healthcare and their particular organizations.


The process is informed by 20 years of providing healthcare leaders with insights for strategic operating and investment decisions. It is inclusive, iterative, data-rich, and can be done remotely.


With a 20+ year record of successfully modeling healthcare volumes, supply and demand, and competitive market dynamics across the spectrum of providers, we know how public and private spend can be modeled to help forecast overall patient volumes nationally and locally. We have a range of traditional and creative datasets at our fingertips and understand how to conduct large-scale primary research with consumers, healthcare professionals, and providers. Healthcare choices are complex, and there is a tremendous amount of data to bring together and model to provide strong parameters on patient volumes and market share potential, for management teams and investors for the short and long term.




Contact Us

Read More

The Strategic Risk System: How ESG, SCRM, EHS, and GRC Are Converging
By Anuj A. Shah, Andrew Keller, Owen Tindle, & Marissa Licursi March 13, 2026
Learn why ESG, SCRM, EHS, and GRC software are converging around strategic risk management and how investors evaluate durable risk platforms.
3 Takeaways from Expo West 2026: What Investors Should Watch in Natural & Better-For-You CPG
March 12, 2026
Expo West 2026 revealed key trends shaping natural and better-for-you CPG. Explore three insights investors should watch, from fiber innovation to clean labels.
Kelsey Chisholm Named Among The Consulting Report’s Top 25 Women Leaders in Consulting for 2026
By Kelsey Chisholm February 25, 2026
"The Consulting Report" is pleased to announce The Top 25 Women Leaders in Consulting for 2026, including our very own Kelsey Chisholm (Partner). Click here to read more.
By Rob Larson, Jordan Abrams February 17, 2026
A recap of Grant Thornton Stax and Raymond James’ healthcare breakfast on PE investment opportunities across the pharma tech ecosystem.
How AI is Reshaping Vertical SaaS
By Kelsey Chisholm & Palash Misra February 12, 2026
AI is driving a bifurcation between surface-layer productivity tools and core operational platforms within vertical software. Learn how Ai is reshaping vertical SaaS here.
Vault Top 50: Four Years Running
February 11, 2026
For four straight years, Grant Thornton Stax has earned a spot on the Vault Consulting Top 50 list of the best consulting firms to work for in North America. Read more here.
Show More